slides · global inventory
Resolution
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 42,534
Current window 23,701-23,730
Pages 1,418
Rows per page 30
Beat
23,701-23,730 of 42,534
61
The slide presents two separate tables for YTD 2021 and YTD 2020, detailing specific line-item adjustments.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
62
Includes footnotes regarding asset impairment definitions and segment reporting structure.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
63
The table reconciles GAAP to non-GAAP figures by adding back acquisition-related costs and adjustments.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
64
The slide provides a detailed breakdown of non-GAAP financial adjustments.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
65
This is a standard financial disclosure slide providing a bridge between GAAP and non-GAAP metrics.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
66
The table is split into two main sections: the left side calculates organic revenue for 2020/2019 periods, and the right side calculates organic revenue growth by comparing 2019/2018 periods.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
67
The table reconciles reported revenue to organic revenue by adjusting for exchange rates, divestitures, and discontinuations.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
68
The table is split into two main sections: one adjusting for exchange rates and one adjusting for divestitures/discontinuations, leading to a final organic growth calculation.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
69
The table adjusts reported revenue for exchange rates and divestitures to arrive at organic revenue.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
70
The slide provides a bridge between GAAP and non-GAAP cash flow metrics by adding back specific legal and separation costs.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
71
Reconciliation of non-GAAP financial measures.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
72
The right-hand sidebar acts as a navigation menu for the appendix section.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
73
The slide includes a sidebar listing various non-GAAP financial measures.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
74
The right-hand sidebar lists specific non-GAAP metrics, while the main body text explains the rationale for excluding specific items like share-based compensation, acquisition costs, and debt extinguishment.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
75
The right-hand sidebar lists various non-GAAP financial measures covered in the appendix.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
76
The slide serves as a glossary/disclosure for non-GAAP metrics used in the presentation.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
77
The right-hand sidebar acts as a navigation menu for the appendix section.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
78
The right sidebar acts as a navigation menu for the appendix section.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
79
The right-hand sidebar acts as a navigation menu for the appendix section.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
17
Includes a map showing trial locations and a legend for treatment arms.BioNTech | Results Presentation Deck | 30 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
18
Includes a citation of a Science paper and histological evidence of CLDN6 expression patterns.BioNTech | Results Presentation Deck | 30 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
19
The slide outlines a clinical trial structure (Phase 1/2a) for a CAR-T therapy.BioNTech | Results Presentation Deck | 30 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
20
The slide title mentions 'First 2 Patients' but the table includes data for 3 patients.BioNTech | Results Presentation Deck | 30 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
21
Includes a process flow diagram and a bar chart showing cytokine response.BioNTech | Results Presentation Deck | 30 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
22
BioNTech | Results Presentation Deck | 30 slidesBioNTech | Results Presentation Deck | 30 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
23
The table shows a significant increase in commercial revenues and a shift from operating loss to profit.BioNTech | Results Presentation Deck | 30 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
24
The chart uses a stacked bar to visualize revenue composition, with a bracket specifically isolating the COVID-19 vaccine revenue portion.BioNTech | Results Presentation Deck | 30 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
25
BioNTech | Results Presentation Deck | 30 slidesBioNTech | Results Presentation Deck | 30 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
26
BioNTech | Results Presentation Deck | 30 slidesBioNTech | Results Presentation Deck | 30 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
27
BioNTech | Results Presentation Deck | 30 slidesBioNTech | Results Presentation Deck | 30 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit